Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum-pemetrexed for T790M mutation-positive advanced non–small cell lung cancer
- Vassiliki A. Papadimitrakopoulou
- , Ji Youn Han
- , Myung Ju Ahn
- , Suresh S. Ramalingam
- , Angelo Delmonte
- , Te Chun Hsia
- , Janessa Laskin
- , Sang We Kim
- , Yong He
- , Chun Ming Tsai
- , Toyoaki Hida
- , Makoto Maemondo
- , Terufumi Kato
- , Suzanne Jenkins
- , Sabina Patel
- , Xiangning Huang
- , Gianluca Laus
- , Aleksandra Markovets
- , Kenneth S. Thress
- , Yi Long Wu
- University of Texas MD Anderson Cancer Center
- National Cancer Center
- Emory University
- IRCCS Istituto scientifico romagnolo per lo studio e la cura dei tumori - Meldola (FC)
- China Medical University Taichung
- Provincial Health Services Authority
- University of Ulsan
- Daping Hospital, the Third Military Medical University
- Veterans General Hospital-Taipei
- Aichi Cancer Center Hospital and Research Institute
- Iwate Medical University
- Kanagawa Cancer Center Research Institute
- AstraZeneca
- Guangdong Academy of Medical Sciences
- Chinese University of Hong Kong
Research output: Contribution to journal › Article › peer-review
106
Link opens in a new tab
Scopus
citations